首页> 外文期刊>Innovations in food technology >NattoPharma highlights new evidence connecting statin use to increased cardiovascular risk, illustrating the impact of Vitamin K2 supplementation for statin users
【24h】

NattoPharma highlights new evidence connecting statin use to increased cardiovascular risk, illustrating the impact of Vitamin K2 supplementation for statin users

机译:Nattopharma突出了将他汀类药物用于增加心血管风险的新证据,说明维生素K2对他汀类药物的影响

获取原文
获取原文并翻译 | 示例
           

摘要

A NEW CROSS-SECTIONAL clinical study published in Kaohsiung Journal of Medical Sciences adds to the evidence that statins, a heavily prescribed cholesterol medication, may enhance calcium accumulation in the arterial wall by inhibiting vitamin K-dependent proteins involved in vascular protection.Statins are first line drugs in the prevention and treatment of established atherosclerotic cardiovascular disease. Paradoxically, intensive statin therapy has been shown to increase vascular calcification and accelerate its progression. The aim of the recently published study, "Statins, vascular calcification, and vitamin K-dependent proteins: Is there a relation?", was to find a putative relation between statin use, coronary calcification, and the vitamin K-dependent proteins as a possible mechanism mediating statins' pro-calcification.
机译:在高雄医科杂志上发表的新横断面临床研究增加了他汀类药物,巨大规定的胆固醇药物,可以通过抑制血管保护中涉及的维生素K依赖性蛋白增强动脉壁的钙积累.statins是首先的 预防和治疗成立动脉粥样硬脑病的预防和治疗方法。 矛盾的是,已经证明了强烈的他汀类药物治疗增加血管钙化并加速其进展。 最近发表的研究的目的,“他汀类药物,血管钙化和维生素K依赖性蛋白质:有条不紊?”,是在他汀类药物使用,冠状动脉钙化和维生素K依赖性蛋白质之间找到一个推定的关系 可能的机制调解他汀类药物的亲钙化。

著录项

  • 来源
    《Innovations in food technology》 |2021年第91期|91-91|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号